Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53

United States Fiscal year ends December CIK 0001652130 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

Bought (12 mo)

$1.40M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.27M

$478.92K on a plan · $836.38K straight out of an exercise

Sold at will

$955.93K

12 of 19 sales

Net

−$868.72K

+$446.57K against sales at will